Literature DB >> 30230114

Radiomics Analysis of Multiparametric MRI Evaluates the Pathological Features of Cervical Squamous Cell Carcinoma.

Qingxia Wu1, Dapeng Shi1, Shewei Dou1, Ligang Shi2, Mingbo Liu3, Li Dong4, Xiaowan Chang5, Meiyun Wang1.   

Abstract

BACKGROUND: Robust parameters to evaluate pathological aggressiveness are needed to provide individualized therapy for cervical cancer patients.
PURPOSE: To investigate the radiomics analysis of multiparametric MRI to evaluate tumor grade, lymphovascular space invasion (LVSI), and lymph node (LN) metastasis of cervical squamous cell carcinoma (CSCC). STUDY TYPE: Retrospective.
SUBJECTS: Fifty-six patients with histopathologically confirmed CSCC. FIELD STRENGTH/SEQUENCE: 3T, axial T2 and T2 with fat suppression (FS), diffusion-weighted imaging (DWI) (multi-b values), axial dynamic contrast enhanced (DCE) MRI (8 sec temporal resolution). ASSESSMENT: Regions of interest were drawn around the tumor on each axial slice and fused to generate the whole tumor volume. Sixty-six radiomics features were derived from each image sequence, including axial T2 and T2 FS, ADC maps, and Ktrans , Ve , and Vp maps from DCE MRI. STATISTICAL TESTS: A univariate analysis was performed to assess each parameter's association with tumor grade and the presence of lymphovascular space invasion (LVSI) and lymph node (LN) metastasis. A principal component analysis was employed for dimension reduction and to generate new discriminative valuables. Using logistic regression, a discriminative model of each parameter was built and a receiver operating characteristic curve (ROC) was generated.
RESULTS: The area under the ROC curve (AUC) of anatomical, diffusion, and permeability parameters in discriminating the presence of LVSI ranged from 0.659 to 0.814, with Ve showing the best discriminative value. The AUC in discriminating the presence of LN metastasis and distinguishing tumor grade ranged from 0.747 to 0.850, 0.668 to 0.757, with ADC and Ve showing the best discriminative value, respectively. DATA
CONCLUSION: Functional maps exhibit better discriminative values than anatomical images for discriminating the pathological features of CSCC, with ADC maps showing the best discrimination performance for LN metastasis and Ve maps showing the best discriminative value for LVSI and tumor grade. LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;49:1141-1148.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  diffusion weighted imaging; dynamic contrast enhanced; magnetic resonance imaging; radiomics analysis; uterine cervical carcinoma

Year:  2018        PMID: 30230114     DOI: 10.1002/jmri.26301

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  15 in total

1.  PET/MRI and PET/CT Radiomics in Primary Cervical Cancer: A Pilot Study on the Correlation of Pelvic PET, MRI, and CT Derived Image Features.

Authors:  Shadi A Esfahani; Angel Torrado-Carvajal; Barbara Juarez Amorim; David Groshar; Liran Domachevsky; Hanna Bernstine; Dan Stein; Debra Gervais; Onofrio A Catalano
Journal:  Mol Imaging Biol       Date:  2021-10-07       Impact factor: 3.488

2.  Combination of Radiomics and Machine Learning with Diffusion-Weighted MR Imaging for Clinical Outcome Prognostication in Cervical Cancer.

Authors:  Ankush Jajodia; Ayushi Gupta; Helmut Prosch; Marius Mayerhoefer; Swarupa Mitra; Sunil Pasricha; Anurag Mehta; Sunil Puri; Arvind Chaturvedi
Journal:  Tomography       Date:  2021-08-05

3.  A preoperative radiomics model for the identification of lymph node metastasis in patients with early-stage cervical squamous cell carcinoma.

Authors:  Lifen Yan; Huasheng Yao; Ruichun Long; Lei Wu; Haotian Xia; Jinglei Li; Zaiyi Liu; Changhong Liang
Journal:  Br J Radiol       Date:  2020-10-06       Impact factor: 3.039

4.  Impact of different scanners and acquisition parameters on robustness of MR radiomics features based on women's cervix.

Authors:  Honglan Mi; Mingyuan Yuan; Shiteng Suo; Jiejun Cheng; Suqin Li; Shaofeng Duan; Qing Lu
Journal:  Sci Rep       Date:  2020-11-23       Impact factor: 4.379

5.  Multi-Parametric Magnetic Resonance Imaging-Based Radiomics Analysis of Cervical Cancer for Preoperative Prediction of Lymphovascular Space Invasion.

Authors:  Gang Huang; Yaqiong Cui; Ping Wang; Jialiang Ren; Lili Wang; Yaqiong Ma; Yingmei Jia; Xiaomei Ma; Lianping Zhao
Journal:  Front Oncol       Date:  2022-01-12       Impact factor: 6.244

6.  Prediction of out-of-field recurrence after chemoradiotherapy for cervical cancer using a combination model of clinical parameters and magnetic resonance imaging radiomics: a multi-institutional study of the Japanese Radiation Oncology Study Group.

Authors:  Hitoshi Ikushima; Akihiro Haga; Ken Ando; Shingo Kato; Yuko Kaneyasu; Takashi Uno; Noriyuki Okonogi; Kenji Yoshida; Takuro Ariga; Fumiaki Isohashi; Yoko Harima; Ayae Kanemoto; Noriko Ii; Masaru Wakatsuki; Tatsuya Ohno
Journal:  J Radiat Res       Date:  2022-01-20       Impact factor: 2.724

7.  Predicting T and N Staging of Resectable Gastric Cancer According to Whole Tumor Histogram Analysis About a Non-Cartesian k-Space Acquisition DCE-MRI: A Feasibility Study.

Authors:  Liangliang Yan; Jinrong Qu; Jing Li; Hongkai Zhang; Yanan Lu; Jianbo Gao
Journal:  Cancer Manag Res       Date:  2021-10-18       Impact factor: 3.989

8.  Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.

Authors:  Yanfen Fan; Yixing Yu; Ximing Wang; Mengjie Hu; Chunhong Hu
Journal:  BMC Med Imaging       Date:  2021-06-15       Impact factor: 1.930

9.  Preoperative Prediction of Lymphovascular Space Invasion in Cervical Cancer With Radiomics -Based Nomogram.

Authors:  Wei Du; Yu Wang; Dongdong Li; Xueming Xia; Qiaoyue Tan; Xiaoming Xiong; Zhiping Li
Journal:  Front Oncol       Date:  2021-07-12       Impact factor: 6.244

10.  Preoperative magnetic resonance imaging criteria for predicting lymph node metastasis in patients with stage IB1-IIA2 cervical cancer.

Authors:  Fangjie He; Shuiling Zu; Xia Chen; Jianping Liu; Ying Yi; Haijun Yang; Fuqiang Wang; Songhua Yuan
Journal:  Cancer Med       Date:  2021-07-18       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.